STAT+: Hospitals Sue Again to Block Trump Administration’s 340B Rebate Pilot Program

AI justification

[Auto-resolved by learned corrector: learned-map — A=MINT/B=MINT -> MINT (human chose this in 87% of 272 past reviews)] Lawsuit against cost-saving drug pricing reforms risks systemic disruption and delays, outweighing immediate access benefits. | The lawsuit aims to protect upfront drug discounts for vulnerable patients, aligning with SDG 3 (Good Health) and SDG 10 (Reduced Inequalities). However, it also introduces regulatory uncertainty and may hinder cost-saving reforms, creating a tension b